Showing results (101-110 of 109) with videos related to
Sort By:
Pageof 11
You have reached the last page of results.This site can display upto 109 results.
Cancer Treatment Reports|May 1, 1976
DTIC (nsc-45388) and combination therapy for melanoma. I. Studies with DTIC, BCNU (NSC-409962), CCNU (NSC-79037), vincristine (NSC-67574), and hydroxyurea (NSC-32065)R D Carter, E T Krementz, G J Hill, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 1, 1986
Effect of alternating combination chemotherapy on survival of ambulatory patients with metastatic large-cell and adenocarcinoma of the lung. A Southwest Oncology Group StudyT P Miller, T T Chen, C A Coltman, et al.Cancer|March 15, 1985
Results of a 400-patient carcinoembryonic antigen second-look colorectal cancer studyJ P Minton, J L Hoehn, D M Gerber, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 17, 1998
Southwest Oncology Group phase II trial of concurrent carboplatin, etoposide, and radiation for poor-risk stage III non-small-cell lung cancerD H Lau, J J Crowley, D R Gandara, et al.Cancer Treatment Reports|September 1, 1986
Randomized comparisons of radiotherapy and carmustine versus procarbazine versus dacarbazine for the treatment of malignant gliomas following surgery: a Southwest Oncology Group StudyH J Eyre, J R Eltringham, E A Gehan, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 1, 1994
Randomized trial of vitamin A versus observation as adjuvant therapy in high-risk primary malignant melanoma: a Southwest Oncology Group studyF L Meyskens, P Y Liu, R J Tuthill, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 20, 1998
Phase II study of carmustine, dacarbazine, cisplatin, and tamoxifen in advanced melanoma: a Southwest Oncology Group studyK A Margolin, P Y Liu, L E Flaherty, et al.Journal of Cancer Research and Clinical Oncology|June 8, 1999
Phase II trial of biochemotherapy with interferon alpha, dacarbazine, cisplatin and tamoxifen in metastatic melanoma: a Southwest Oncology Group trialK A Margolin, P Y Liu, J M Unger, et al.American Journal of Clinical Oncology|April 1, 1983
Adriamycin versus adriamycin plus cis-diamminedichloroplatinum (DDP) in advanced transitional cell bladder carcinoma. A Southwest Oncology Group studyR Gagliano, H Levin, M N El-Bolkainy, et al.Pageof 11